Related Experiment Video
Updated: May 8, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Mild acute ischaemic stroke--the case for thrombolytic therapy
Waldo R Guerrero1, Sean I Savitz
1Stroke Program, Department of Neurology, University of Texas Medical School, 6431 Fannin, Houston, TX 77030, USA.
Mild ischemic stroke (MIS) is increasing, yet many patients aren't treated with intravenous recombinant tissue plasminogen activator (rtPA). This review explores treatment barriers and advocates for rtPA in MIS patients, emphasizing the need for clinical trials.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Stroke: Introduction and Types

